86
Participants
Start Date
May 13, 2022
Primary Completion Date
November 30, 2023
Study Completion Date
December 15, 2023
Cilta-cel
Cilta-cel will be administered as an IV infusion.
Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
Lymphodepleting therapy (cyclophosphamide and fludarabine) will be administered intravenously.
Mount Sinai Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
University of Pittsburgh Medical Center, Pittsburgh
Levine Cancer Institute, Charlotte
Emory University, Atlanta
Barbara Ann Karmanos Cancer Institute, Detroit
Medical College Of Wisconsin, Milwaukee
Northwestern University, Chicago
Washington University School Of Medicine, St Louis
Kansas University Medical Center, Westwood
MD Anderson Cancer Center, Houston
Colorado Blood Cancer Institute, Denver
City of Hope, Duarte
University of California San Francisco, San Francisco
Stanford University Medical Center, Stanford
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Janssen Scientific Affairs, LLC
INDUSTRY